A juxtamembrane tyrosine in the colony stimulating factor-1 receptor regulates ligand-induced Src association,

Cynthia M Rohde1, Jason Schrum, Angel W-M Lee

  • 1Department of Pharmacology, University of Michigan Medical School, Ann Arbor 48109, USA.

Insights

The colony stimulating factor-1 (CSF-1) receptor's Tyr559 residue acts as a regulatory switch. Mutations impairing Src family kinase binding lead to hyperproliferation and altered receptor regulation, suggesting implications for cancer.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cancer Research

Background:

  • The juxtamembrane domain (JMD) of receptor tyrosine kinases plays a regulatory role.
  • Mutations in c-Kit and Flt3 JMDs are linked to gastrointestinal stromal tumors and acute myeloid leukemias.
  • Autophosphorylated Tyr559 in the colony stimulating factor-1 (CSF-1) receptor (CSF-1R) JMD binds to Src family kinases (SFKs).

Purpose of the Study:

  • To investigate the function of SFKs in CSF-1 signaling.
  • To elucidate the role of Tyr559 in CSF-1R regulation and signaling.

Main Methods:

  • Established stable 32D myeloid cell lines expressing CSF-1Rs with mutated SFK binding sites (Tyr559-TFI).
  • Assessed SFK association, intrinsic kinase activity, autophosphorylation, and downstream signaling pathways (Akt, ERK, Stat5).
  • Analyzed receptor ubiquitination, internalization, degradation, and interaction with c-Cbl.

Main Results:

  • Mutants Y559F and Y559D showed markedly decreased CSF-1-dependent SFK association.
  • Y559F and Y559D mutants exhibited reduced CSF-1-induced autophosphorylation.
  • Y559F mutant cells were hyperproliferative, with prolonged Akt, ERK, and Stat5 activation, reduced c-Cbl association, and impaired receptor down-regulation.

Conclusions:

  • Tyr559 functions as a switch residue regulating CSF-1R kinase activity, signal transduction, and receptor down-regulation.
  • Impaired SFK binding at Tyr559 leads to hyperproliferation and altered receptor trafficking.
  • These findings may inform understanding of oncogenic mutations in c-Kit and Flt3 JMDs.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...